Gary Zieziula
Director/Board Member at INNOVENT BIOLOGICS, INC.
Net worth: 23 493 $ as of 30/03/2024
Profile
Gary J.
Zieziula currently works at Innovent Biologics, Inc., as Independent Non-Executive Director from 2022.
Mr. Zieziula also formerly worked at EMD Serono, Inc., as President & Managing Director, Bristol Myers Squibb Co., as VP-Sales & Cardiovascular Metabolic Products, Merck & Co., Inc., as Vice President-Sales, and AMAG Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2010 to 2011.
Mr. Zieziula received his Masters Business Admin degree in 1983 from Canisius College and undergraduate degree in 1976 from State University of New York at Buffalo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC.
0.00% | 21/03/2024 | 4,877 ( 0.00% ) | 23 493 $ | 30/03/2024 |
Gary Zieziula active positions
| Companies | Position | Start |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Director/Board Member | 30/05/2022 |
Former positions of Gary Zieziula
| Companies | Position | End |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | President | 31/08/2018 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 03/11/2011 |
| MERCK & CO., INC. | Sales & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | - |
Training of Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Gary Zieziula
